SGHT News and Press, Sight Sciences Inc. From 08/31/21

Of your five senses, eye sight ranks up there as most important, and essential. Unfortunately, for some of us, we don’t have the best vision. In fact, some of us deal with what’s known as Aniseikonia, or as noted by Clinical and Experimental Optometry “is a difference i...

MENLO PARK, Calif., Aug. 26, 2021 (GLOBE NEWSWIRE) -- Sight Sciences, Inc . (Nasdaq: SGHT), a growth-stage medical device company focused on developing and commercializing devices designed to address the underlying causes of the world's most prevalent eye diseases, today announced p...

MENLO PARK, Calif., Aug. 24, 2021 (GLOBE NEWSWIRE) -- Sight Sciences, Inc . (Nasdaq: SGHT), a growth-stage medical device company focused on developing and commercializing devices designed to address the underlying causes of the world's most prevalent eye diseases, today announced p...

Sight Sciences, Inc. (SGHT) Q2 2021 Earnings Conference Call August 13, 2021 05:00 PM ET Company Participants Philip Taylor - IR Paul Badawi - CEO Jesse Selnick - CFO Conference Call Participants Cecilia Furlong - Morgan Stanley Presentation Operator Good day Ladies and gentlemen, and welcome...

MENLO PARK, Calif., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform standards of care and improve patients’ lives, today reported financial results for the quarter ende...

You can read full article here. For further details see: Wall Street Breakfast: The Week Ahead (Podcast)

MENLO PARK, Calif., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Sight Sciences, Inc . (Nasdaq: SGHT) today announced it will report financial results for the second quarter 2021 after the market close on Thursday, August 12, 2021. The company’s management will discuss the results durin...

Shares of Sight Sciences Inc. (NASDAQ:SGHT) traded today at $38.36, eclipsing its 52-week high. This new high was reached on below average trading volume as 119,000 shares traded hands, while the average 30-day volume is approximately 365,000 shares. Sight Sciences Inc is a growth-stage ...

MENLO PARK, Calif., July 22, 2021 (GLOBE NEWSWIRE) -- Sight Sciences, Inc . (Nasdaq: SGHT), a growth-stage medical device company focused on addressing the underlying causes of the world's most prevalent eye diseases, today announced that data from multiple retrospective and prospec...

Medical device maker Sight Sciences (SGHT) closed its IPO and raised about $276M in gross proceeds.The eye-disease focused company sold 11.5M common shares, including the exercise in full of the underwriters’ option to by 1.5 additional shares, at $24 each.The company's stock...